Related Experiment Video
Updated: May 25, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia
Kristen Tropea1, Helen Christou
1Division of Newborn Medicine, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA.
Insights
Bronchopulmonary dysplasia (BPD), a complication of preterm birth, arises from complex factors like ventilator injury and oxygen exposure. This review examines current and future pharmacological treatments to prevent and manage BPD.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Critical Care Medicine
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication following preterm birth.
- It leads to severe, long-term adverse health outcomes in affected infants.
- The exact causes of BPD are complex, multifactorial, and not fully understood.
Purpose of the Study:
- This review aims to discuss current evidence for pharmacological interventions in BPD.
- It also seeks to identify promising future therapeutic strategies for BPD prevention and management.
Main Methods:
- The review synthesizes existing research on BPD pathogenesis and treatment.
- It evaluates current preventive and therapeutic strategies, including ventilator management, oxygen therapy, and nutritional support.
- Evidence for pharmacological interventions is critically assessed.
Main Results:
- Current strategies, including lung-protective ventilation and specific interventions, show variable success.
- Pharmacological and nutritional approaches target different aspects of BPD.
- These interventions are often used in combination for optimal effect.
Conclusions:
- A deeper understanding of BPD pathogenesis is crucial for developing novel preventive approaches.
- Future therapeutic modalities show promise in managing BPD.
- Rigorous evaluation of new strategies within current clinical practice is essential to confirm efficacy.
Abstract:
Bronchopulmonary dysplasia (BPD) is a major complication of preterm birth and has serious adverse long-term health consequences. The etiology of BPD is complex, multifactorial, and incompletely understood. Contributing factors include ventilator-induced lung injury, exposure to toxic oxygen levels, and infection. Several preventive and therapeutic strategies have been developed with variable success. These include lung protective ventilator strategies and pharmacological and nutritional interventions. These strategies target different components and stages of the disease process and they are commonly used in combination. The purpose of this review is to discuss the evidence for current pharmacological interventions and identify future therapeutic modalities that appear promising in the prevention and management of BPD. Continued improved understanding of BPD pathogenesis leads to opportunities for newer preventive approaches. These will need to be evaluated in the setting of current clinical practice in order to assess their efficacy.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)